Association of overexpression of TIF1γ with colorectal carcinogenesis and advanced colorectal adenocarcinoma

AIM:To determine the expression and clinical significance of transcriptional intermediary factor 1 gamma (TIF1γ),Smad4 and transforming growth factor-beta (TGFβR) across a spectrum representing colorectal cancer (CRC) development.METHODS:Tissue microarrays were prepared from archival paraffin embedd...

Full description

Saved in:
Bibliographic Details
Published in:World journal of gastroenterology : WJG Vol. 17; no. 35; pp. 3994 - 4000
Main Authors: Jain, Shilpa, Singhal, Shashideep, Francis, Franto, Hajdu, Cristina, Wang, Jin-Hua, Suriawinata, Arief, Wang, Yin-Quan, Zhang, Miao, Weinshel, Elizabeth H, Francois, Fritz, Pei, Zhi-Heng, Lee, Peng, Xu, Ru-Liang
Format: Journal Article
Language:English
Published: United States Baishideng Publishing Group Co., Limited 21-09-2011
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:AIM:To determine the expression and clinical significance of transcriptional intermediary factor 1 gamma (TIF1γ),Smad4 and transforming growth factor-beta (TGFβR) across a spectrum representing colorectal cancer (CRC) development.METHODS:Tissue microarrays were prepared from archival paraffin embedded tissue,including 51 colorectal carcinomas,25 tubular adenomas (TA) and 26 HPs,each with matched normal colonic epithelium.Immunohistochemistry was performed using antibodies against TIF1γ,Smad4 and TGFβ RⅡ.The levels of expression were scored semi-quantitatively (score 0-3 or loss and retention for Smad4).RESULTS:Overexpression of TIF1γ was detected in 5/26 (19%) HP;however,it was seen in a significantly higher proportion of neoplasms,15/25 (60%) TAs and 24/51 (47%) CRCs (P0.05).Normal colonic mucosa,HP,and TAs showed strong Smad4 expression,while its expression was absent in 22/51 (43%) CRCs.Over- expression of TGFβ RⅡ was more commonly seen in neoplasms,13/25 (52%) TAs and 29/51 (57%) CRCs compared to 9/26 (35%) HP (P0.05).Furthermore,there was a correlation between TIF1γ overexpression and Smad4 loss in CRC (Kendall tau rank correlation value=0.35,P0.05).The levels of TIF1γ overexpression were significantly higher in stage Ⅲ than in stage Ⅰ and Ⅱ CRC (P0.05).CONCLUSION:The findings suggest that over-expression of TIF1γ occurs in early stages of colorectal carcinogenesis,is inversely related with Smad4 loss,and may be a prognostic indicator for poor outcome.
Bibliography:AIM:To determine the expression and clinical significance of transcriptional intermediary factor 1 gamma (TIF1γ),Smad4 and transforming growth factor-beta (TGFβR) across a spectrum representing colorectal cancer (CRC) development.METHODS:Tissue microarrays were prepared from archival paraffin embedded tissue,including 51 colorectal carcinomas,25 tubular adenomas (TA) and 26 HPs,each with matched normal colonic epithelium.Immunohistochemistry was performed using antibodies against TIF1γ,Smad4 and TGFβ RⅡ.The levels of expression were scored semi-quantitatively (score 0-3 or loss and retention for Smad4).RESULTS:Overexpression of TIF1γ was detected in 5/26 (19%) HP;however,it was seen in a significantly higher proportion of neoplasms,15/25 (60%) TAs and 24/51 (47%) CRCs (P0.05).Normal colonic mucosa,HP,and TAs showed strong Smad4 expression,while its expression was absent in 22/51 (43%) CRCs.Over- expression of TGFβ RⅡ was more commonly seen in neoplasms,13/25 (52%) TAs and 29/51 (57%) CRCs compared to 9/26 (35%) HP (P0.05).Furthermore,there was a correlation between TIF1γ overexpression and Smad4 loss in CRC (Kendall tau rank correlation value=0.35,P0.05).The levels of TIF1γ overexpression were significantly higher in stage Ⅲ than in stage Ⅰ and Ⅱ CRC (P0.05).CONCLUSION:The findings suggest that over-expression of TIF1γ occurs in early stages of colorectal carcinogenesis,is inversely related with Smad4 loss,and may be a prognostic indicator for poor outcome.
14-1219/R
Shilpa Jain,Shashideep Singhal,Franto Francis,Cristina Hajdu,Jin-Hua Wang,Arief Suriawinata,Yin-Quan Wang,Miao Zhang,Elizabeth H Weinshel,Fritz Francois,Zhi-Heng Pei,Peng Lee,Ru-Liang Xu Shilpa Jain,Franto Francis,Cristina Hajdu,Miao Zhang,Zhi-Heng Pei,Ru-Liang Xu,Department of Pathology,New York University School of Medicine,New York,NY 10016,United States Shashideep Singhal,Department of Medicine,The Brooklyn Hospital Center,Brooklyn,NY 11201,United States Arief Suriawinata,Dartmouth-Hitchcock Medical Center,Lebanon,NH 03756,United States Jin-Hua Wang,NYU Cancer Institute,New York University School of Medicine,New York,NY 10016,United States Yin-Quan Wang,Department of General Surgery,the First Hospital of Shanxi Medical University,030001 Taiyuan,Shanxi Province,China Elizabeth H Weinshel,Fritz Francois,Department of Medicine,New York University School of Medicine,New York,NY 10016,United States Peng Lee,NYU Cancer Institute,New York University School of Medicine,and New York Harbor Healthcare System,New York,NY 10016,United States
Colorectal cancer; Transcriptional intermediary factor 1 gamma; Transforming growth factor-beta signaling pathway; Smad4
Telephone: +1-212-2630728 Fax: +1-212-2637916
Author contributions: Jain S, Singhal S, Francis F, Hajdu C, Wang JH, Suriawinata A, Wang YQ, Zhang M, Lee P and Xu RL performed the study and wrote the manuscript; Weinshel EH, Francois F, Pei ZH participated in manuscript preparation and /or research design.
Correspondence to: Ru-Liang Xu, MD, PhD, Department of Pathology, New York University School of Medicine, 560 First Avenue, New York, NY 10593, United States. ruliang.xu@nyumc.org
ISSN:1007-9327
2219-2840
DOI:10.3748/wjg.v17.i35.3994